Overdose risks increase as demand for injectable weight loss drugs on the rise, research finds UAB News Benefits of GLP 1 (Glucagon Like Peptide 1) Receptor Agonists for Stroke Reduction in Type 2 Diabetes: A Call to Action for Neurologists Stroke What is BPC 157 and why are people talking about it? BPC 157 is a synthetic peptide derived from a protein found in gastric juice. Most of the data we have comes from animal Key Findings: Duration Reduction: The study found that GLP 1 therapy significantly shortens the duration of BoNT A effects: In chronic migraine treatment, the mean duration dropped from 14.0 weeks to between 11.8 Substack Series 2 of 6, GLP 1 Receptor Agonists: Mechanisms and Clinical Applications Current Status of Glucagon like Peptide 1 Receptor Agonists in Metabolic Dysfunction associated Steatotic Liver Disease: A Clinical Perspective